Evidence map›Paper›PMID 39060840›Full record

Trial reportPrevention science : the official journal of the Society for Prevention Research2024

Acceptability of Four Intervention Components Supporting Medication Adherence in Women with Breast Cancer: a Process Evaluation of a Fractional Factorial Pilot Optimization Trial.

Sophie M C Green, Nikki Rousseau, Louise H Hall, David P French, Christopher D Graham, Kelly E Lloyd, Michelle Collinson, Pei Loo Ow, Christopher Taylor, Daniel Howdon and 10 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Prevention science : the official journal of the Society for Prevention Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sophie M C GreenLeeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL. S.m.c.green@leeds.ac.uk.ORCID 0000-0002-2622-5377
Nikki RousseauLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Louise H HallLeeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
David P FrenchManchester Centre for Health Psychology, University of Manchester, Manchester, UK, M13 9PL.
Christopher D GrahamDepartment of Psychological Sciences & Health, University of Strathclyde, Glasgow, G1 1QE, Scotland.
Kelly E LloydLeeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
Michelle CollinsonLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Pei Loo OwLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Christopher TaylorLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Daniel HowdonLeeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
Robbie FoyLeeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
Rebecca WalwynLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Jane ClarkDepartment of Clinical and Health Psychology, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
Catherine ParbuttMedicines Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
Jo WallerWolfson Institute of Population Health, Queen Mary University of London, London, UK.
Jacqueline BuxtonIndependent, Leeds, UK.
Sally J L MooreIndependent, Leeds, UK.
Galina VelikovaLeeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK, LS9 7TF.
Amanda FarrinLeeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Samuel G SmithLeeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.

Funding

Manchester Biomedical Research Centre IS-BRC-1215-20007Manchester Biomedical Research Centre NIHR203308National Institute for Health and Care Research NIHR300588Yorkshire Cancer Research L417
6 · The paper itself

Abstract

Adjuvant endocrine therapy (AET) reduces mortality in early-stage breast cancer, but adherence is low. We developed a multicomponent intervention to support AET adherence comprising: text messages, information leaflet, acceptance and commitment therapy (ACT), and side-effect website. Guided by the multiphase optimization strategy, the intervention components were tested in the ROSETA pilot optimization trial. Our mixed-methods process evaluation investigated component acceptability. The pilot optimization trial used a 2

Indexed as

Breast NeoplasmsMedication AdherenceAdultAgedFemaleHumansMiddle AgedPilot ProjectsSurveys and QuestionnairesAcceptabilityBreast cancerFactorialMedication adherenceProcess evaluation

Identifiers

PMID39060840
PMCPMC11519312

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.